Vera Therapeutics earnings were -$134.4M for the trailing 12 months ending Sep 30, 2024, with N/A growth year over year. The latest VERA earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$46.6M, up 38.3% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, VERA reported annual earnings of -$96.0M, with 7.8% growth.
What were Vera Therapeutics's earnings last quarter?
Vera Therapeutics (NASDAQ: VERA) reported Q3 2024 earnings per share (EPS) of -$0.85, up 88.89% year over year. Total VERA earnings for the quarter were -$46.63 million. In the same quarter last year, Vera Therapeutics's earnings per share (EPS) was -$0.45.
As of the last Vera Therapeutics earnings report, Vera Therapeutics is currently losing money. Vera Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was -$134.38 million, a 30.75% increase year over year.
What was VERA's earnings growth in the past year?
As of Vera Therapeutics's earnings date in Q4 2024, Vera Therapeutics's earnings has grown year over year. VERA earnings in the past year totalled -$134.38 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.